glpg2451
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02788721)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glpg2451
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03540524 | Phase 1 | May 31, 2018 | Galapagos NV |
| NCT03214614 | Phase 1 | Nov 14, 2016 | Galapagos NV |
| NCT02788721 | Phase 1 | May 1, 2016 | Galapagos NV, Pharmaceutical Research Associates, Inc. (PRA), SGS Life Sciences |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galapagos NV | For profit | 3 | 3 | 1 | 2016 |
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2016 |
| SGS Life Sciences | For profit | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1